Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Paper
  • Published:

Protective immunization against melanoma by gp100 DNA–HVJ-liposome vaccine

Abstract

DNA-based vaccine immunization effectively induces both humoral and cell-mediated immunity to antigens and can confer protection against numerous infectious diseases as well as some cancers. Human and mouse melanomas consistently express the tumor-associated antigen interacted with the melanogenesis pathway. Gp100 is immunogenic and has been shown to induce both antibody and cytotoxic T cell (CTL) responses in humans. To explore the potential use of DNA immunization to induce melanoma-specific immune responses, we assessed HVJ-AVE liposome incorporated with plasmid DNA encoding human gp100. The gp100 DNA vaccine was used in a mouse melanoma model to assess immunity against the B16 melanoma of C57BL/6 mice. Intramuscular injection of the DNA–HVJ-AVE liposomes induced both anti-gp100 antibody and CTL responses. Gp100 DNA–HVJ-AVE liposome immunization significantly delayed tumor development in mice challenged with B16 melanoma cells. Mice immunized with gp100 DNA–HVJ-AVE liposomes survived longer compared with control mice immunized with HVJ-AVE liposome alone. These results indicate that immunization with human gp100 DNA by HVJ-AVE liposomes can induce protective immunity against melanoma in this pre-clinical mouse model. This strategy may provide an effective approach for vaccine therapy with tumor-associated antigens against human melanoma.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. Ho TY et al. DNA vaccination induces a long-term antibody response and protective immunity against pseudorabies virus in mice Arch Virol 1998 143: 115–125

    Article  CAS  PubMed  Google Scholar 

  2. Larsen DL et al. Coadminstration of DNA encoding interleukin-6 and hemagglutinin confers protection from influenza virus challenge in mice J Virol 1998 72: 1704–1708

    CAS  PubMed  PubMed Central  Google Scholar 

  3. Iwasaki A, Barber BH . Induction by DNA immunization of a protective antitumor cytotoxic T lymphocyte response against a minimal-epitope-expressing tumor Cancer Immunol Immunother 1994 45: 273–279

    Article  Google Scholar 

  4. Chen Y et al. DNA vaccines encoding full-length or truncated Neu induce protective immunity against Neu-expressing mammary tumors Cancer Res 1998 58: 1965–1971

    CAS  PubMed  Google Scholar 

  5. Schreurs MWJ, de Boer A, Figdor CG, Adema GJ . Genetic vaccination against the melanocyte lineage-specific antigen gp100 induces cytotoxic T lymphocyte-mediated protection Cancer Res 1998 58: 2509–2514

    CAS  PubMed  Google Scholar 

  6. Kawakami Y et al. Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection Proc Natl Acad Sci USA 1994 91: 6458–6462

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Zhai Y et al. Antigen-specific tumor vaccines: development and characterization of recombinant adenoviruses encoding MART1 or gp100 for cancer therapy J Immunol 1996 156: 700–710

    CAS  PubMed  Google Scholar 

  8. Huang SKS et al. Antibody responses to melanoma/melanocyte auto-antigens in melanoma patients J Invest Dermatol 1998 111: 662–667

    Article  CAS  PubMed  Google Scholar 

  9. Zhai Y et al. Cloning and characterization of the genes encoding the mouse homologues of the human melanoma antigen MART 1 and gp100 J Immunother 1997 20: 15–25

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Sarantou T et al. Melanoma-associated antigen as messenger RNA detection markers for melanoma Cancer Res 1997 57: 1371–1376

    CAS  PubMed  Google Scholar 

  11. Okamoto T et al. Induction of antibody response to human tumor antigens by gene therapy using a fusigenic viral liposome vaccine Gene Therapy 1997 4: 969–976

    Article  CAS  PubMed  Google Scholar 

  12. Hirano K et al. Persistent gene expression in rat liver in vivo by repetitive transfections using HVJ-liposome Gene Therapy 1998 5: 459–464

    Article  CAS  PubMed  Google Scholar 

  13. Saeki Y et al. Development and characterization of cationic liposomes conjugated with HVJ (Sendai virus): reciprocal effect of cationic lipid for in vivo and in vitro gene transfer Hum Gene Ther 1997 8: 2133–2141

    Article  CAS  PubMed  Google Scholar 

  14. Nakanishi M et al. Efficient induction of contents of liposomes into cells using HVJ (Sendai virus) Exp Cell Res 1985 159: 399–409

    Article  CAS  PubMed  Google Scholar 

  15. Kaneda Y et al. The improved efficient method for introducing macromolecules into cells using HVJ (Sendai virus) liposomes with gangliosides Exp Cell Res 1987 173: 56–69

    Article  CAS  PubMed  Google Scholar 

  16. Kaneda Y Iwai K, Uchida T . Increased expression of DNA cointroduced with nuclear protein in adult rat liver Science 1989 243: 375–378

    Article  PubMed  Google Scholar 

  17. Kaneda Y, Iwai K, Uchida T . Introduction and expression of the human Insulin gene in adult rat liver J Biol Chem 1989 264: 12126–12129

    CAS  PubMed  Google Scholar 

  18. Morishita R et al. Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal by perplasia Proc Natl Acad Sci USA 1993 90: 8474–8478

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Morishita R et al. Novel and effective gene transfer technique for study of vascular renin angiotensin system J Clin Invest 1993 91: 2580–2585

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Hoon DSB, Irie RF . Current status of human melanoma vaccines Can they control malignant melanoma? BioDrugs 1997 1: 66–84

    Google Scholar 

  21. Morton DL et al. Prolongation of survival in metastatic melanoma after active specific immunotherapy with new polyvalent melanoma vaccine Ann Surg 1992 216: 463–482

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Baniyash M et al. Serologically detectable MHC and tumor-associated antigens on B16 melanoma variants and humoral immunity in mice bearing these tumors J Immunol 1982 129: 1318–1323

    CAS  PubMed  Google Scholar 

  23. Schearer GM, Rehn TG, Garbarino CA . Cell-mediated lympholysis of trinitrophenyl-modified autologous lymphocytes J Exp Med 1975 141: 1348–1364

    Article  Google Scholar 

  24. Zinkernagel RM, Dohetry OC . Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic chorio-meningitis within a syngenic or semiallogenic system Nature 1974 248: 701–702

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by a grant for an international joint work provided by the Ministry of Education, Science and Culture of Japan.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhou, WZ., Kaneda, Y., Huang, S. et al. Protective immunization against melanoma by gp100 DNA–HVJ-liposome vaccine. Gene Ther 6, 1768–1773 (1999). https://doi.org/10.1038/sj.gt.3300998

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3300998

Keywords

This article is cited by

Search

Quick links